Skip to search formSkip to main contentSkip to account menu

KSG 504

Known as: KSG-504 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

NaphthalenesPentanoic Acids

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The work of child protection groups in Austria
SummaryAIM: To document the number of child protection groups (CPG) in children’s hospitals and paediatric surgeries in Austria… 
1996
1996
Effects of KSG-504, a new cholecystokinin-A-receptor antagonist, on pancreatic exocrine and endocrine secretions in rats.
The effects of KSG-504 ((S)-arginium (R)-4-[N-(3-methoxypropyl)-N-pentylcarbamoyl]-5-(2-naphthylsulf onyl) pentanoate monohydrate… 
1996
1996
[Effect of KSG-504, a new CCK-A-receptor antagonist, on experimental acute pancreatitis in rats and mice].
We investigated the protective and/or therapeutic effects of a new cholecystokinin receptor antagonist, KSG-504, on different… 
1996
1996
[Effects of KSG-504, a new CCK-A receptor antagonist, on gallbladder and gastrointestinal functions].
We investigated the interaction of KSG-504 with CCK-8- or pentagastrin-induced gallbladder and gastrointestinal responses in… 
1995
1995
Different Inhibitory Effects of the Newly Developed CCK Receptor Antagonists FK480 and KSG‐504 on Pancreatic Exocrine and Endocrine Secretion in the Isolated Perfused Rat Pancreas
Cholecystokinin (CCK) receptor antagonists are shown to have therapeutic as well as preventive effects in some types of acute… 
1995
1995
Cholecystokinin-A specific antagonism of KSG-504 to cholecystokinin receptor binding and pancreatic secretion in mammals.
The effects of KSG-504 ((S)-arginium (R)-4-[-N-(3-methoxypropyl)-N-pentylcarbamoyl]-5-(2- naphthylsulfonyl) pentanoate… 
1994
1994
A New CCK‐A Antagonist, KSG‐504, Administered Intraduodenally, Inhibits Pancreatic Secretion in Rats
We studied the effect in anesthetized rats of a new cholecystokinin (CCK) receptor antagonist developed in Japan, KSG-504… 
1994
1994
Effect of a New Cholecystokinin Receptor Antagonist (KSG 504) on the Early Stage of the Healing Process in Acute Pancreatitis Induced in Rats by the Closed Duodenal Loop Technique
Creation of a closed duodenal loop produced edematous acute pancreatitis within 6 h and hemorrhagic acute pancreatitis within 12… 
1993
1993
Pharmacological profile of KSG-504, a new cholecystokinin-A-receptor antagonist.
Pharmacological effects of KSG-504, a newly synthetized compound, on the response induced by exogenous CCK-8 were investigated… 
1993
1993
[Effect of KSG-504, a new synthetic cholecystokinin receptor antagonist on ethionine-induced acute pancreatitis in rats].
KSG-504, a new synthetic cholecystokinin (CCK) receptor antagonist derived from proglumide, has superior selectivity and affinity… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)